인바디

041830KOSDAQ

51.0 / 100

Reference Date: 2026-10-23

Financial Score21.5 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Plunged 17.3% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

InBody is a global medical equipment manufacturer established in 1996, specializing in body composition analyzers, automatic blood pressure monitors, and home-use body composition analyzers. With 83% of sales generated overseas, the company achieved a 14.4% revenue increase to 233.9 billion won in 2025.

Number of Employees

370people

Average Salary

52.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

19.79Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

2.02Industry Average 1.201.0Point

1.7x industry avg (risky)

ROE

10.10Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

2.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.2% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 12.8% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (47%)

Current 47,950Won52-week high 70,80052-week low 26,950

1-month return0.0Point

1m -17.33% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-10-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-30